|
|
|
(State or other jurisdiction
of incorporation or organization)
|
(I.R.S. employer identification number)
|
|
|
|
|
|
||
|
||
(Address of principal executive offices)
|
(Zip code)
|
|
|
|
|
(Registrant’s telephone number, including area code)
|
Title of each class
|
Trading symbol(s)
|
Name of each exchange on which registered
|
|
|
|
|
☒
|
Accelerated filer
|
☐
|
Non-accelerated filer
|
☐
|
Smaller reporting company
|
|
Emerging growth company
|
|
Page
|
||
For the three months ended
|
|||||
March 29,
2020 |
|
March 31,
2019 |
|
||
Revenue
|
|
|
|
|
|
Cost of revenue
|
(
|
)
|
(
|
)
|
|
Gross profit
|
|
|
|
|
|
Research and development
|
(
|
)
|
(
|
)
|
|
Selling, general and administrative
|
(
|
)
|
(
|
)
|
|
Amortization of acquisition-related intangible assets
|
(
|
)
|
(
|
)
|
|
Total operating expenses
|
(
|
)
|
(
|
)
|
|
Other income (expense)
|
|
|
|
|
|
Operating income (loss)
|
|
|
|
|
|
Financial income (expense):
|
|||||
Other financial income (expense)
|
(
|
)
|
(
|
)
|
|
Income (loss) before income taxes
|
(
|
)
|
(
|
)
|
|
Benefit (provision) for income taxes
|
(
|
)
|
|
|
|
Results relating to equity-accounted investees
|
(
|
)
|
|
|
|
Net income (loss)
|
(
|
)
|
(
|
)
|
|
Less: Net income (loss) attributable to non-controlling interests
|
|
|
|
|
|
Net income (loss) attributable to stockholders
|
(
|
)
|
(
|
)
|
|
Earnings per share data:
|
|||||
Net income (loss) per common share attributable to stockholders in $
|
|||||
Basic
|
(
|
)
|
(
|
)
|
|
Diluted
|
(
|
)
|
(
|
)
|
|
Weighted average number of shares of common stock outstanding during the period (in thousands):
|
|||||
Basic
|
|
|
|
|
|
Diluted
|
|
|
|
|
For the three months ended
|
|||||
March 29,
2020 |
|
March 31,
2019 |
|
||
Net income (loss)
|
(
|
)
|
(
|
)
|
|
Other comprehensive income (loss), net of tax:
|
|||||
Change in fair value cash flow hedges
|
(
|
)
|
|
|
|
Change in foreign currency translation adjustment
|
(
|
)
|
(
|
)
|
|
Change in net actuarial gain (loss)
|
(
|
)
|
(
|
)
|
|
Total other comprehensive income (loss)
|
(
|
)
|
(
|
)
|
|
Total comprehensive income (loss)
|
(
|
)
|
(
|
)
|
|
Less: Comprehensive income (loss) attributable to non-controlling interests
|
|
|
|
|
|
Total comprehensive income (loss) attributable to stockholders
|
(
|
)
|
(
|
)
|
March 29,
2020 |
|
December 31,
2019 |
|
|||
ASSETS
|
||||||
Current assets:
|
||||||
Cash and cash equivalents
|
|
|
|
|
||
Accounts receivable, net
|
|
|
|
|
||
Assets held for sale
|
|
|
|
|
||
Inventories, net
|
|
|
|
|
||
Other current assets
|
|
|
|
|
||
Total current assets
|
|
|
|
|
||
Non-current assets:
|
||||||
Other non-current assets
|
|
|
|
|
||
Property, plant and equipment, net of accumulated depreciation of $3,842 and $3,742
|
|
|
|
|
||
Identified intangible assets, net of accumulated amortization of $6,113 and $5,764
|
|
|
|
|
||
Goodwill
|
|
|
|
|
||
Total non-current assets
|
|
|
|
|
||
Total assets
|
|
|
|
|
||
LIABILITIES AND EQUITY
|
||||||
Current liabilities:
|
||||||
Accounts payable
|
|
|
|
|
||
Restructuring liabilities-current
|
|
|
|
|
||
Other current liabilities
|
|
|
|
|
||
Total current liabilities
|
|
|
|
|
||
Non-current liabilities:
|
||||||
Long-term debt
|
|
|
|
|
||
Deferred tax liabilities
|
|
|
|
|
||
Other non-current liabilities
|
|
|
|
|
||
Total non-current liabilities
|
|
|
|
|
||
Total liabilities
|
|
|
|
|
||
Equity:
|
||||||
Non-controlling interests
|
|
|
|
|
||
Stockholders’ equity:
|
||||||
Common stock, par value €0.20 per share:
|
|
|
|
|
||
Capital in excess of par value
|
|
|
|
|
||
Treasury shares, at cost:
|
||||||
36,518,520 shares (2019: 34,082,242 shares)
|
(
|
)
|
(
|
)
|
||
Accumulated other comprehensive income (loss)
|
|
|
|
|
||
Accumulated deficit
|
(
|
)
|
(
|
)
|
||
Total stockholders’ equity
|
|
|
|
|
||
Total equity
|
|
|
|
|
||
Total liabilities and equity
|
|
|
|
|
For the three months ended
|
|||||
March 29,
2020 |
|
March 31,
2019 |
|
||
Cash flows from operating activities:
|
|||||
Net income (loss)
|
(
|
)
|
(
|
)
|
|
Adjustments to reconcile net income (loss) to net cash provided by (used for) operating activities:
|
|||||
Depreciation and amortization
|
|
|
|
|
|
Share-based compensation
|
|
|
|
|
|
Amortization of discount on debt
|
|
|
|
|
|
Amortization of debt issuance costs
|
|
|
|
|
|
Net (gain) loss on sale of assets
|
(
|
)
|
|
|
|
Results relating to equity-accounted investees
|
|
|
(
|
)
|
|
Deferred tax expense (benefit)
|
(
|
)
|
(
|
)
|
|
Changes in operating assets and liabilities:
|
|
||||
(Increase) decrease in receivables and other current assets
|
|
|
(
|
)
|
|
(Increase) decrease in inventories
|
(
|
)
|
|
|
|
Increase (decrease) in accounts payable and other liabilities
|
|
|
(
|
)
|
|
Decrease (increase) in other non-current assets
|
|
|
|
|
|
Exchange differences
|
(
|
)
|
|
|
|
Other items
|
|
|
|
|
|
Net cash provided by (used for) operating activities
|
|
|
|
|
|
Cash flows from investing activities:
|
|||||
Purchase of identified intangible assets
|
(
|
)
|
(
|
)
|
|
Capital expenditures on property, plant and equipment
|
(
|
)
|
(
|
)
|
|
Purchase of interests in businesses, net of cash acquired
|
(
|
)
|
|
|
|
Proceeds from sale of interests in businesses
|
|
|
|
|
|
Purchase of investments
|
|
|
(
|
)
|
|
Proceeds from sale of investments
|
|
|
|
|
|
Net cash provided by (used for) investing activities
|
(
|
)
|
(
|
)
|
|
Cash flows from financing activities:
|
|||||
Dividends paid to common stockholders
|
(
|
)
|
(
|
)
|
|
Proceeds from issuance of common stock through stock plans
|
|
|
|
|
|
Purchase of treasury shares and restricted stock unit withholdings
|
(
|
)
|
(
|
)
|
|
Net cash provided by (used for) financing activities
|
(
|
)
|
(
|
)
|
|
Effect of changes in exchange rates on cash positions
|
(
|
)
|
(
|
)
|
|
Increase (decrease) in cash and cash equivalents
|
|
|
(
|
)
|
|
Cash and cash equivalents at beginning of period
|
|
|
|
|
|
Cash and cash equivalents at end of period
|
|
|
|
|
As of
|
|||||
March 29,
2020 |
|
March 31,
2019 |
|
||
Supplemental disclosures to the condensed consolidated cash flows
|
|||||
Net cash paid during the period for:
|
|||||
Interest
|
|
|
|
|
|
Income taxes
|
|
|
|
|
|
Net gain (loss) on sale of assets:
|
|||||
Cash proceeds from the sale of assets
|
|
|
|
|
|
Book value of these assets
|
(
|
)
|
(
|
)
|
|
Non-cash investing activities:
|
|||||
Non-cash capital expenditures
|
|
|
|
|
Outstanding
number of
shares (in
thousands)
|
|
Common
stock
|
|
Capital in
excess of
par value
|
|
Treasury
shares at
cost
|
|
Accumulated
other
comprehensive
income (loss)
|
|
Accumulated
deficit
|
|
Total
stock-
holders’
equity
|
|
Non-
controlling
interests
|
|
Total
equity
|
|
||||||||||
Balance as of December 31, 2019
|
|
|
|
|
|
|
(
|
)
|
|
|
(
|
)
|
|
|
|
|
|
|
|||||||||
Net income (loss)
|
|
|
|
|
|
(
|
)
|
(
|
)
|
|
|
(
|
)
|
||||||||||||||
Other comprehensive income
|
|
|
|
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
|||||||||||||||
Share-based compensation plans
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Shares issued pursuant to stock awards
|
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|||||||||||||
Treasury shares and restricted stock unit withholdings
|
(
|
)
|
|
|
(
|
)
|
|
|
(
|
)
|
|
(
|
)
|
||||||||||||||
Expiration of stock purchase warrants
|
(
|
)
|
|
|
—
|
|
—
|
|
|||||||||||||||||||
Dividends common stock ($0.375 per share)
|
|
|
|
|
|
(
|
)
|
(
|
)
|
|
(
|
)
|
|||||||||||||||
Balance as of March 29, 2020
|
|
|
|
|
|
|
(
|
)
|
|
|
(
|
)
|
|
|
|
|
|
|
Outstanding
number of
shares (in
thousands)
|
|
Common
stock
|
|
Capital in
excess of
par value
|
|
Treasury
shares at
cost
|
|
Accumulated
other
comprehensive
income (loss)
|
|
Accumulated
deficit
|
|
Total
stock-
holders’
equity
|
|
Non-
controlling
interests
|
|
Total
equity
|
|
||||||||||
Balance as of December 31, 2018
|
|
|
|
|
|
|
(
|
)
|
|
|
(
|
)
|
|
|
|
|
|
|
|||||||||
Net income (loss)
|
|
|
|
|
|
(
|
)
|
(
|
)
|
|
|
(
|
)
|
||||||||||||||
Other comprehensive income
|
|
|
|
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
|||||||||||||||
Share-based compensation plans
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Shares issued pursuant to stock awards
|
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|||||||||||||
Treasury shares and restricted stock unit withholdings
|
(
|
)
|
|
|
(
|
)
|
|
|
(
|
)
|
|
(
|
)
|
||||||||||||||
Shareholder tax on repurchased shares
|
|
|
|
|
|
(
|
)
|
(
|
)
|
|
(
|
)
|
|||||||||||||||
Dividends common stock ($0.25 per share)
|
|
|
|
|
(
|
)
|
(
|
)
|
|
(
|
)
|
||||||||||||||||
Balance as of March 31, 2019
|
|
|
|
|
|
|
(
|
)
|
|
|
(
|
)
|
|
|
|
|
|
|
Tangible fixed assets
|
|
|
Inventory
|
|
|
Identified intangible assets
|
|
|
Goodwill
|
|
|
Deferred tax assets
|
|
|
Net assets acquired
|
|
|
Fair Value
|
Weighted Average Estimated Useful Life (in Years)
|
|||
Customer relationships (included in customer-related)
|
|
|
|
|
Developed technology (included in technology-based)
|
|
|
|
|
In-process research and development
(1)
|
|
|
N/A
|
|
Total identified intangible assets
|
|
|
1)
|
|
For the three months ended
|
|||||
March 29,
2020 |
|
March 31,
2019 |
|
||
Distributors
|
|
|
|
|
|
Original Equipment Manufacturers and Electronic Manufacturing Services
|
|
|
|
|
|
Other
|
|
|
|
|
|
Total
|
|
|
|
|
For the three months ended
|
|||||
March 29,
2020 |
|
March 31,
2019 |
|
||
Depreciation of property, plant and equipment
|
|
|
|
|
|
Amortization of internal use software
|
|
|
|
|
|
Amortization of other identified intangible assets
|
|
|
|
|
|
Total - Depreciation, amortization and impairment
|
|
|
|
|
For the three months ended
|
For the three months ended
|
||||
March 29,
2020 |
|
March 31,
2019 |
|
||
Income from MSA and TSA arrangements
|
|
|
|
|
|
Expenses from MSA and TSA arrangements
|
(
|
)
|
(
|
)
|
|
Result from MSA and TSA arrangements
|
|
|
|
|
|
Other, net
|
|
|
|
||
Total
|
|
|
|
For the three months ended
|
|||||
March 29,
2020 |
|
March 31,
2019 |
|
||
Interest income
|
|
|
|
|
|
Interest expense
|
(
|
)
|
(
|
)
|
|
Total interest expense, net
|
(
|
)
|
(
|
)
|
|
Foreign exchange rate results
|
|
|
(
|
)
|
|
Miscellaneous financing costs/income and other, net
|
(
|
)
|
(
|
)
|
|
Total other financial income/ (expense)
|
|
|
(
|
)
|
|
Total - Financial income and expenses
|
(
|
)
|
(
|
)
|
For the three months ended
|
|||||
March 29,
2020 |
|
March 31,
2019 |
|
||
Net income (loss)
|
(
|
)
|
(
|
)
|
|
Less: net income (loss) attributable to non-controlling interests
|
|
|
|
|
|
Net income (loss) attributable to stockholders
|
(
|
)
|
(
|
)
|
|
Weighted average number of shares outstanding (after deduction of treasury shares) during the year (in thousands)
|
|
|
|
|
|
Plus incremental shares from assumed conversion of:
|
|||||
Options
1)
|
|
|
|
|
|
Restricted Share Units, Performance Share Units and Equity Rights
2)
|
|
|
|
|
|
Warrants
3)
|
|
|
|
|
|
Dilutive potential common shares
|
|
|
|
|
|
Adjusted weighted average number of shares outstanding (after deduction of treasury shares) during the year (in thousands)
|
|
|
|
|
|
EPS attributable to stockholders in $:
|
|||||
Basic net income (loss)
|
(
|
)
|
(
|
)
|
|
Diluted net income (loss)
|
(
|
)
|
(
|
)
|
March 29,
2020 |
|
December 31,
2019 |
|
||
Raw materials
|
|
|
|
|
|
Work in process
|
|
|
|
|
|
Finished goods
|
|
|
|
|
|
|
|
|
|
Currency
translation
differences
|
|
Change in fair
value
cash flow hedges
|
|
Net actuarial
gain/(losses)
|
|
Accumulated
Other
Comprehensive
Income (loss)
|
|
||||
As of December 31, 2019
|
|
|
|
|
(
|
)
|
|
|
|||
Other comprehensive income (loss) before
reclassifications |
(
|
)
|
(
|
)
|
|
|
(
|
)
|
|||
Amounts reclassified out of accumulated other
comprehensive income (loss) |
|
|
|
|
|
|
|
|
|||
Tax effects
|
|
|
|
|
(
|
)
|
(
|
)
|
|||
Other comprehensive income (loss)
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
|||
As of March 29, 2020
|
|
|
(
|
)
|
(
|
)
|
|
|
First Quarter 2020
|
First Quarter 2019
|
|||||||
Dividend per share
|
Amount
|
Dividend per share
|
Amount
|
|
||||
First quarter
|
|
|
|
|
|
Balance January 1, 2020
|
|
Additions
|
|
Utilized
|
|
Released
|
|
Other
changes |
|
Balance Balance as of March 29, 2020
|
|
||||||
Restructuring liabilities
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
For the three months ended
|
|||||
March 29,
2020 |
|
March 31,
2019 |
|
||
Cost of revenue
|
|
|
|
|
|
Research and development
|
|
|
|
|
|
Selling, general and administrative
|
|
|
|
|
|
Net restructuring charges
|
|
|
|
|
For the three months ended
|
|||||
March 29,
2020 |
|
March 31,
2019 |
|
||
Tax expense (benefit)
|
|
|
(
|
)
|
|
Effective tax rate
|
|
%
|
|
%
|
March 29, 2020
|
December 31, 2019
|
||||||||||
Gross carrying
amount
|
|
Accumulated
amortization
|
|
Gross carrying
amount
|
|
Accumulated
amortization
|
|
||||
In-process R&D (IPR&D)
1)
|
|
|
—
|
|
|
|
—
|
|
|||
Marketing-related
|
|
|
(
|
)
|
|
|
(
|
)
|
|||
Customer-related
|
|
|
(
|
)
|
|
|
(
|
)
|
|||
Technology-based
|
|
|
(
|
)
|
|
|
(
|
)
|
|||
Identified intangible assets
|
|
|
(
|
)
|
|
|
(
|
)
|
|||
(1) IPR&D is not subject to amortization until completion or abandonment of the associated research and development effort.
|
2020 (remaining)
|
|
2021
|
|
2022
|
|
2023
|
|
2024
|
|
Thereafter
|
|
March 29, 2020
|
December 31, 2019
|
||||||||||
Maturities
|
Amount
|
|
Effective
rate |
Amount
|
|
Effective
rate |
|||||
Fixed-rate 4.125% senior unsecured notes
|
Jun, 2021
|
|
|
|
|
|
|
||||
Fixed-rate 4.625% senior unsecured notes
|
Jun, 2022
|
|
|
|
|
|
|
||||
Fixed-rate 3.875% senior unsecured notes
|
Sep, 2022
|
|
|
|
|
|
|
||||
Fixed-rate 4.625% senior unsecured notes
|
Jun, 2023
|
|
|
|
|
|
|
||||
Fixed-rate 4.875% senior unsecured notes
|
Mar, 2024
|
|
|
|
|
|
|
||||
Fixed-rate 5.35% senior unsecured notes
|
Mar, 2026
|
|
|
|
|
|
|
||||
Fixed-rate 3.875% senior unsecured notes
|
Jun, 2026
|
|
|
|
|
|
|
||||
Fixed-rate 5.55% senior unsecured notes
|
Dec, 2028
|
|
|
|
|
|
|
||||
Fixed-rate 4.3% senior unsecured notes
|
Jun, 2029
|
|
|
|
|
|
|
||||
Floating-rate revolving credit facility (RCF)
|
Jun, 2024
|
|
|
|
|
|
|
||||
Total principal
|
|
|
|
|
|||||||
Unamortized discounts, premiums and debt
issuance costs |
(
|
)
|
(
|
)
|
|||||||
Total debt, including unamortized discounts,
premiums, debt issuance costs and fair value adjustments |
|
|
|
|
|||||||
Long-term debt
|
|
|
|
|
For the three months ended
|
|
For the three months ended
|
|
||
March 29, 2020
|
|
March 31, 2019
|
|
||
Operating lease cost
|
|
|
|
|
For the three months ended
|
|
For the three months ended
|
|
||
March 29, 2020
|
|
March 31, 2019
|
|
||
Right-of-use assets obtained in exchange for lease obligations:
|
|||||
Operating leases 1)
|
|
|
|
|
|
1) $188 million recorded on January 1, 2019 in accordance with the adoption of ASC 842.
|
|||||
Weighted average remaining lease term:
|
|||||
Operating leases
|
|
|
|
|
|
Weighted average discount rate:
|
|||||
Operating leases
|
|
%
|
|
%
|
As of
|
||
March 29, 2020
|
||
Operating leases
|
||
2020 (remaining)
|
|
|
2021
|
|
|
2022
|
|
|
2023
|
|
|
2024
|
|
|
Thereafter
|
|
|
Total future minimum lease payments
|
|
|
Less: imputed interest
|
(
|
)
|
Total
|
|
|
Operating leases
|
|||||
As of
|
|||||
March 29, 2020
|
December 31, 2019
|
||||
Other current liabilities
|
|
|
|
|
|
Other non-current liabilities
|
|
|
|
|
|
Total
|
|
|
|
|
For the three months ended
|
|||||
March 29,
2020 |
|
March 31,
2019 |
|
||
Revenue and other income
|
|
|
|
|
|
Purchase of goods and services
|
|
|
|
|
March 29,
2020 |
|
December 31,
2019 |
|
||
Receivables
|
|
|
|
|
|
Payables
|
|
|
|
|
March 29, 2020
|
December 31, 2019
|
||||||||||||
Fair value
hierarchy |
Carrying
amount
|
|
Estimated
fair value
|
|
Carrying
amount
|
|
Estimated
fair value
|
|
|||||
Assets:
|
|||||||||||||
Money market funds
|
1
|
|
|
|
|
|
|
|
|
||||
Other financial assets
|
2
|
|
|
|
|
|
|
|
|
||||
Derivative instruments-assets
|
2
|
|
|
|
|
|
|
|
|
||||
Liabilities:
|
|||||||||||||
Long-term debt (bonds)
|
2
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||
Derivative instruments-liabilities
|
2
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
•
|
Overview
- Overall analysis of financial and other highlights to provide context for the MD&A
|
•
|
Results of Operations
- An analysis of our financial results
|
•
|
Liquidity and Capital Resources
- An analysis of changes in our balance sheets and cash flows
|
•
|
Contractual Obligations -
An update on contractual obligations as of December 31, 2019
|
•
|
Off-balance Sheet Arrangements -
An update on off-balance sheet arrangements as of December 31, 2019
|
($ in millions, unless otherwise stated)
|
Q1 2020
|
|
Q1 2019
|
|
|
Revenue
|
2,021
|
2,094
|
|
||
Gross profit
|
997
|
1,072
|
|
||
Operating income (loss)
|
68
|
|
54
|
|
|
Cash flow from operating activities
|
512
|
296
|
|
||
Total debt
|
7,366
|
7,340
|
|
||
Net debt
|
6,287
|
5,148
|
|
||
Diluted weighted average number of shares outstanding
|
279,933
|
|
287,227
|
|
|
Diluted net income per share
|
(0.08)
|
(0.07
|
)
|
||
Dividends per common share
|
0.375
|
|
0.25
|
|
($ in millions, unless otherwise stated)
|
Q1 2020
|
|
Q1 2019
|
|
|
Revenue
|
2,021
|
2,094
|
|
||
% nominal growth
|
(3.5
|
)
|
(7.7
|
)
|
|
Gross profit
|
997
|
1,072
|
|
||
Research and development
|
(425)
|
(415
|
)
|
||
Selling, general and administrative
|
(233)
|
(248
|
)
|
||
Amortization of acquisition-related intangible assets
|
(381)
|
(357
|
)
|
||
Other income (expense)
|
110
|
2
|
|
||
Operating income (loss)
|
68
|
|
54
|
|
($ in millions, unless otherwise stated)
|
Q1 2020
|
|
Q1 2019
|
|
Change
|
|
||
Automotive
|
994
|
|
1,036
|
|
(4.1
|
)%
|
||
Industrial & IoT
|
376
|
|
368
|
|
2.2
|
%
|
||
Mobile
|
247
|
|
241
|
|
2.5
|
%
|
||
Communication Infrastructure & Other
|
404
|
|
449
|
|
(10.0
|
)%
|
||
Revenue
|
2,021
|
|
2,094
|
|
(3.5
|
)%
|
($ in millions, unless otherwise stated)
|
Q1 2020
|
|
Q1 2019
|
|
Change
|
|
||
Distributors
|
984
|
|
962
|
|
2.3
|
%
|
||
OEM/EMS
|
1,000
|
|
1,114
|
|
(10.2
|
)%
|
||
Other
|
37
|
|
18
|
|
105.6
|
%
|
||
Revenue
|
2,021
|
|
2,094
|
|
(3.5
|
)%
|
($ in millions, unless otherwise stated)
|
Q1 2020
|
|
Q1 2019
|
|
Change
|
|
||
Greater China (including Asia Pacific)
|
1,068
|
|
1,098
|
|
(2.7
|
)%
|
||
EMEA (Europe, the Middle East and Africa)
|
441
|
|
441
|
|
—
|
%
|
||
Americas
|
254
|
|
268
|
|
(5.2
|
)%
|
||
Japan
|
170
|
|
207
|
|
(17.9
|
)%
|
||
South Korea
|
88
|
|
80
|
|
10.0
|
%
|
||
Revenue
|
2,021
|
|
2,094
|
|
(3.5
|
)%
|
n
|
Automotive
|
n
|
Industrial IoT
|
n
|
Mobile
|
n
|
Comm Infra & Other
|
n
|
Distributors
|
n
|
OEM/EMS
|
n
|
Other
|
($ in millions, unless otherwise stated)
|
Q1 2020
|
|
Q1 2019
|
|
|
Research and development
|
425
|
|
415
|
|
|
Selling, general and administrative
|
233
|
|
248
|
|
|
Amortization of acquisition-related intangible assets
|
381
|
|
357
|
|
|
Operating expenses
|
1,039
|
|
1,020
|
|
($ in millions)
|
Q1 2020
|
|
Q1 2019
|
|
|
Income from MSA and TSA arrangements
|
33
|
|
26
|
|
|
Expenses from MSA and TSA arrangements
|
(33
|
)
|
(24
|
)
|
|
Result from MSA and TSA arrangements
|
—
|
|
2
|
|
|
Other, net
|
110
|
|
—
|
|
|
Total
|
110
|
|
2
|
|
($ in millions, unless otherwise stated)
|
Q1 2020
|
|
Q1 2019
|
|
|
Interest income
|
4
|
|
13
|
|
|
Interest expense
|
(82
|
)
|
(87
|
)
|
|
Total interest expense, net
|
(78
|
)
|
(74
|
)
|
|
Foreign exchange rate results
|
4
|
|
(6
|
)
|
|
Extinguishment of debt
|
—
|
|
—
|
|
|
Miscellaneous financing costs/income and other, net
|
(4
|
)
|
(3
|
)
|
|
Total other financial income (expense)
|
—
|
|
(9
|
)
|
|
Total
|
(78
|
)
|
(83
|
)
|
($ in millions, unless otherwise stated)
|
Q1 2020
|
|
Q1 2019
|
|
|
Operating income (loss)
|
68
|
|
54
|
|
|
Financial income (expense)
|
(78
|
)
|
(83
|
)
|
|
Benefit (provision) for income taxes
|
(2
|
)
|
9
|
|
|
Results relating to equity-accounted investees
|
(1
|
)
|
4
|
|
|
Net income (loss)
|
(13
|
)
|
(16
|
)
|
($ in millions, unless otherwise stated)
|
Q1 2020
|
|
Q1 2019
|
|
|
Net cash provided by (used for) operating activities
|
512
|
|
296
|
|
|
Net cash provided by (used for) investing activities
|
(37
|
)
|
(136
|
)
|
|
Net cash provided by (used for) financing activities
|
(431
|
)
|
(756
|
)
|
|
Net cash increase (decrease) in cash and cash equivalents
|
44
|
|
(596
|
)
|
Period ended
|
|||||
($ in millions)
|
Q1 2020
|
|
Q1 2019
|
|
|
Dividends paid to common stockholders
|
(105
|
)
|
(73
|
)
|
|
Cash proceeds from exercise of stock options and savings from ESPP
|
29
|
|
32
|
|
|
Purchase of treasury shares
|
(355
|
)
|
(715
|
)
|
Period
|
Total Number
of Shares Purchased |
Average Price
Paid per Share |
Number of Shares Purchased as Part of Publicly Announced Buy Back Programs
|
Maximum Number of
Shares That May Yet Be Purchased Under the Buy Back Program |
Number of Shares Purchased as Trade for Tax (1)
|
|||||||||
January 1, 2020 – February 2, 2020
|
1,667,700
|
|
$131.24
|
1,667,700
|
|
14,040,094
|
|
—
|
|
|||||
February 3, 2020 – March 1, 2020
|
272,469
|
|
$130.03
|
239,700
|
|
15,392,552
|
|
32,769
|
|
|||||
March 2, 2020 – March 29, 2020
|
992,989
|
|
$101.00
|
991,789
|
|
20,293,318
|
|
1,200
|
|
|||||
Total
|
2,933,158
|
|
2,899,189
|
|
33,969
|
|
Exhibit
Number
|
Exhibit Description
|
||
3.1
|
|||
3.2
|
|||
10.1+
|
|||
10.2+
|
|||
10.3+
|
|||
10.4*+
|
|||
10.5*+
|
|||
31.1*
|
|||
31.2*
|
|||
32.1**
|
|||
101
|
The following materials from the Company’s Quarterly Report on Form 10-Q for the quarter ended March 29, 2020, formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) Condensed Consolidated Statements of Operations for the three months ended March 29, 2020 and March 31, 2019; (ii) Condensed Consolidated Statements of Comprehensive Income for the three months ended March 29, 2020 and March 31, 2019; (iii) Condensed Consolidated Balance Sheets as of March 29, 2020 and December 31, 2019; (iv) Condensed Consolidated Statements of Cash Flows for the three months ended March 29, 2020 and March 31, 2019; (v) Condensed Consolidated Statements of Changes in Equity for the three months ended March 29, 2020 and March 31, 2019; and (vi) Notes to the Unaudited Condensed Consolidated Financial Statements.
|
||
104
|
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).
|
+
|
Indicates management contract or compensatory plan or arrangement.
|
*
|
Filed herewith.
|
**
|
Furnished herewith.
|
NXP Semiconductors N.V.
|
|
/s/ P. Kelly
|
|
Name: P. Kelly, CFO
|
|
1.
|
I have reviewed this quarterly report on Form 10-Q of NXP Semiconductors N.V.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;
|
4.
|
The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:
|
a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c)
|
Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d)
|
Disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and
|
5.
|
The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent functions):
|
a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize, and report financial information; and
|
b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.
|
By:
|
/s/ Richard L. Clemmer
|
|
Richard L. Clemmer
|
||
Chief Executive Officer
|
1.
|
I have reviewed this quarterly report on Form 10-Q of NXP Semiconductors N.V.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;
|
4.
|
The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:
|
a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c)
|
Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d)
|
Disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and
|
5.
|
The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent functions):
|
a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize, and report financial information; and
|
b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.
|
By:
|
/s/ Peter Kelly
|
|
Peter Kelly
|
||
Chief Financial Officer
|
By:
|
/s/ Richard L. Clemmer
|
|
Richard L. Clemmer
|
||
Chief Executive Officer
|
By:
|
/s/ Peter Kelly
|
|
Peter Kelly
|
||
Chief Financial Officer
|